Merus N.V. (MRUS) Financials

MRUS Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 904.2 million 129.3 million
June 30, 2025 980.2 million 138.4 million
March 31, 2025 730.9 million 134.8 million
Dec. 31, 2024 785.1 million 134.8 million

MRUS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -85.2 million 21.0 million
June 30, 2025 -69.3 million 20.4 million
March 31, 2025 -96.6 million 14.8 million
Dec. 31, 2024 -66.7 million 15.9 million

MRUS Net Income

No data available :(

MRUS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 635.9 million - -
June 30, 2025 710.2 million 8.8 million 11.0 million
March 31, 2025 458.3 million 8.1 million 9.9 million
Dec. 31, 2024 537.0 million 8.2 million 9.9 million

MRUS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 75.7 million
June 30, 2025 71.1 million
March 31, 2025 69.0 million
Dec. 31, 2024 68.8 million

MRUS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 328000 80.0 million 28.6 million -
June 30, 2025 88000 79.7 million 21.4 million -
March 31, 2025 171000 74.1 million 20.4 million -
Dec. 31, 2024 20000 84.2 million 22.6 million -

MRUS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 12.2 million -
June 30, 2025 7.5 million 79.7 million
March 31, 2025 24.5 million 74.1 million
Dec. 31, 2024 9.1 million 607000

MRUS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MRUS

Price: $90

52 week price:
33.19
97.14

Earnings Per Share: -5.28 USD

P/E Ratio: -17.05

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Netherlands

Volume: 272700

Ebitda: -11.8 million

Market Capitalization: 6.8 billion

Links: